当前位置:首页 - 行情中心 - 塞力医疗(603716) - 财务分析 - 现金流量表

塞力医疗

(603716)

  

流通市值:32.06亿  总市值:32.06亿
流通股本:2.26亿   总股本:2.26亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金456,764,237.95252,892,797.891,295,765,455.48996,764,675.8
  收到其他与经营活动有关的现金427,424.82386,068.5418,814,418.141,296,095.48
  经营活动现金流入小计457,191,662.77253,278,866.431,314,579,873.62998,060,771.28
  购买商品、接受劳务支付的现金330,093,432.77183,063,211.72965,494,029.05735,129,606.04
  支付给职工以及为职工支付的现金84,837,842.6247,043,271.65181,387,279.27133,869,352.83
  支付的各项税费25,223,734.3313,171,986.8376,655,527.2565,096,149.55
  支付其他与经营活动有关的现金51,820,260.224,399,005.92128,795,040.7888,565,177.02
  经营活动现金流出小计491,975,269.92267,677,476.121,352,331,876.351,022,660,285.44
  经营活动产生的现金流量净额-34,783,607.15-14,398,609.69-37,752,002.73-24,599,514.16
二、投资活动产生的现金流量:
  收回投资收到的现金900,466.55-4,010,000-
  取得投资收益收到的现金1,575.061,575.062,545.551,689.56
  处置固定资产、无形资产和其他长期资产收回的现金净额81,453.3381,453.33133,542.45325,647.69
  处置子公司及其他营业单位收到的现金净额--40,400,00041,434,586.33
  收到的其他与投资活动有关的现金3,662,902.024,478,560.5744,815,848.519,285,848.5
  投资活动现金流入小计4,646,396.964,561,588.9689,361,936.561,047,772.08
  购建固定资产、无形资产和其他长期资产支付的现金879,921.08617,772.085,718,905.835,329,235.72
  投资支付的现金17,096,736.6414,217,415.4333,686,54519,634,699.68
  支付其他与投资活动有关的现金6,268,750.4-19,743,178.53-
  投资活动现金流出小计24,245,408.1214,835,187.5159,148,629.3624,963,935.4
  投资活动产生的现金流量净额-19,599,011.16-10,273,598.5530,213,307.1436,083,836.68
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,500,000-1,423,517.2905,517.2
  其中:子公司吸收少数股东投资收到的现金1,500,000-1,423,517.2905,517.2
  取得借款收到的现金105,577,911.7450,043,784.59317,827,673.15258,482,482.49
  收到其他与筹资活动有关的现金7,729,6007,079,297.0870,432,580.1431,123,100
  筹资活动现金流入小计114,807,511.7457,123,081.67389,683,770.49290,511,099.69
  偿还债务支付的现金58,635,535.9414,000,000326,697,139.95246,030,000
  分配股利、利润或偿付利息支付的现金9,991,955.213,059,610.0329,244,620.6524,796,982.75
  其中:子公司支付给少数股东的股利、利润3,920,000359,30010,687,079.66-
  支付其他与筹资活动有关的现金27,380,267.9210,058,925.38111,583,123.8100,107,226.16
  筹资活动现金流出小计96,007,759.0727,118,535.41467,524,884.4370,934,208.91
  筹资活动产生的现金流量净额18,799,752.6730,004,546.26-77,841,113.91-80,423,109.22
四、汇率变动对现金及现金等价物的影响803.251,681.63-649-36,940.48
五、现金及现金等价物净增加额-35,582,062.395,334,019.65-85,380,458.5-68,975,727.18
  加:期初现金及现金等价物余额122,104,025.42122,104,025.42207,484,483.92207,484,483.92
  期末现金及现金等价物余额86,521,963.03127,438,045.07122,104,025.42138,508,756.74
补充资料:
  净利润-51,509,745.89--201,442,576.54-
  资产减值准备1,212,495.67-53,947,696.8-
  固定资产和投资性房地产折旧12,054,081.17-26,615,466.42-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧12,054,081.17-26,615,466.42-
  无形资产摊销1,110,776.05-2,118,865.85-
  长期待摊费用摊销3,691,461.41-7,253,357.82-
  处置固定资产、无形资产和其他长期资产的损失-37,511.89-248,367.57-
  固定资产报废损失237,030.14-5,673,953.79-
  财务费用5,101,136.37-33,527,170.19-
  投资损失1,607,910.51--5,672,676.42-
  递延所得税-8,344,489.94-38,340,084.11-
  其中:递延所得税资产减少-8,413,379.6-42,563,397.36-
    递延所得税负债增加68,889.66--4,223,313.25-
  存货的减少28,410,704.04-102,776,957.47-
  经营性应收项目的减少80,992,334--32,029,596.55-
  经营性应付项目的增加-119,353,672.33--74,180,331.66-
  现金的期末余额86,521,963.03-122,104,025.42-
  减:现金的期初余额122,104,025.42-207,484,483.92-
  现金及现金等价物的净增加额-35,582,062.39--85,380,458.5-
公告日期2026-08-282026-04-292026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑